Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05180812 · ClinicalTrials.gov registry record · NA

Safety and Feasibility of ExoNET

A NA study of Stroke and Cerebral Vascular Accident, sponsored by Shirley Ryan AbilityLab.

Active
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT05180812 is a NA study of Stroke and Cerebral Vascular Accident that is active but no longer recruiting, run by Shirley Ryan AbilityLab. The registered enrollment target is 20 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05180812, a NA study of Stroke and Cerebral Vascular Accident, is active but no longer recruiting, sponsored by Shirley Ryan AbilityLab.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate the safety, feasibility, and preliminary efficacy of the ExoNET passive robotic device. It will provide upper-extremity gravity compensation for therapeutic movement retraining in the chronic post stroke patient population.

Interventions

  • DEVICE ExoNet Tuned to Gravity Support

Study Locations (1)

Illinois

  • Shirley Ryan AbilityLab - Chicago

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2022-03-01
Est. Completion 2026-07-12
Phase NA

Sponsor

Shirley Ryan AbilityLab

138 total trials

What the Registry Record Tells You About NCT05180812

The ClinicalTrials.gov registry entry for NCT05180812 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The listed sponsor is Shirley Ryan AbilityLab, which has 138 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which ExoNet Tuned to Gravity Support is the first listed.

NCT05180812 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT05180812 about?

NCT05180812 is a clinical study titled "Safety and Feasibility of ExoNET". The purpose of this study is to evaluate the safety, feasibility, and preliminary efficacy of the ExoNET passive robotic device. It will provide upper-extremity gravity compensation for therapeutic movement retraining in the chronic post stroke patient population.

What is the current status of trial NCT05180812?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2022-03-01. Estimated completion is 2026-07-12.

What conditions does trial NCT05180812 study?

This clinical trial studies the following conditions: Stroke, Cerebral Vascular Accident.

What interventions are being tested in trial NCT05180812?

The interventions under investigation include: ExoNet Tuned to Gravity Support (DEVICE).

Who is sponsoring clinical trial NCT05180812?

This trial is sponsored by Shirley Ryan AbilityLab, which has 138 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05180812 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.